BA
ARKG icon

BKS Advisors’s ARK Genomic Revolution ETF ARKG Stock Holding History

BKS Advisors’s Portfolio ARKG Stock Details ARKG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$302K Hold
9,185
– – 0.12% 154
2018
Q4 		$220K Buy
+9,185
New +$259K 0.1% 184

Other funds holding ARKG

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
CFA
Carroll Financial Associates Charlotte, North Carolina $1.88B AUM 20.52% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
CAN
Cetera Advisor Networks El Segundo, California $20.2B AUM 22.31% 1-Year Est. Return
RJFSA
Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return
Carson Wealth (CWM LLC)
Carson Wealth (CWM LLC) Omaha, Nebraska $38.1B AUM 19.66% 1-Year Est. Return
BCM
Barometer Capital Management Toronto, Ontario, Canada $292M AUM 86.78% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $38.8B AUM 21.88% 1-Year Est. Return
SCA
Snowden Capital Advisors New York $3.76B AUM 23.4% 1-Year Est. Return

BKS Advisors's ARKG Position: Q1 2019 in Review

BKS Advisors held its ARK Genomic Revolution ETF (ARKG) position steady in Q1 2019 at 9,185 shares worth $302K. The position accounts for 0.12% of the portfolio, ranked #154.

BKS Advisors first reported a position in ARKG in Q4 2018 and has held it in 2 quarters since. 64 funds tracked by Wall St. Rank hold ARKG as of Q1 2019.

  • BKS Advisors held 9,185 shares of ARK Genomic Revolution ETF worth $302K as of Q1 2019.
  • BKS Advisors left its ARK Genomic Revolution ETF share count unchanged in Q1 2019.
  • ARK Genomic Revolution ETF made up 0.12% of BKS Advisors's portfolio in Q1 2019, its #154 holding.
  • BKS Advisors first reported a position in ARK Genomic Revolution ETF in Q4 2018 and has held it in 2 quarters since.
  • 64 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q1 2019.

Based on BKS Advisors's 13F filing for Q1 2019, filed 16 Apr 2019.